British American Tobacco Bangladesh Company Limited (DSE:BATBC)

Revance Therapeutics Income Statement

Financials in millions BDT. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	91,367	99,449	91,668	84,232	74,828	60,291
Revenue Growth (YoY)	0.05%	8.49%	8.83%	12.57%	24.11%	6.11%
Cost of Revenue	53,662	55,516	47,386	40,198	35,168	30,670
Gross Profit	37,705	43,933	44,282	44,034	39,660	29,620
Selling, General & Admin	10,472	8,243	9,356	8,968	8,864	7,452
Other Operating Expenses	733.34	733.34	1,318	981.3	306.98	266.06
Operating Expenses	11,669	9,440	11,105	10,318	9,515	8,048
Operating Income	26,036	34,493	33,178	33,716	30,145	21,572
Interest Expense	-1,354	-1,037	-583.06	-563.53	-371.8	-326.51
Interest & Investment Income	260.51	273.7	183.62	58.25	37.47	251.5
Other Non Operating Income (Expenses)	1.96	32.3	2,497	1,745	130.86	35.16
EBT Excluding Unusual Items	24,945	33,762	35,275	34,956	29,941	21,532
Gain (Loss) on Sale of Assets	52.6	52.6	-4.69	37.42	-25.43	16.47
Other Unusual Items	-	-	-	-	-14.38	-458.63
Pretax Income	24,997	33,814	35,270	34,993	29,902	21,090
Income Tax Expense	12,591	16,306	17,392	17,121	14,933	10,203
Net Income	12,407	17,508	17,879	17,872	14,969	10,887
Net Income to Common	12,407	17,508	17,879	17,872	14,969	10,887
Net Income Growth	-29.65%	-2.07%	0.04%	19.40%	37.49%	17.74%
Shares Outstanding (Basic)	540	540	540	540	540	540
Shares Outstanding (Diluted)	540	540	540	540	540	540
EPS (Basic)	22.98	32.42	33.11	33.10	27.72	20.16
EPS (Diluted)	22.98	32.42	33.11	33.10	27.72	20.16
EPS Growth	-29.65%	-2.07%	0.04%	19.40%	37.49%	17.74%
Free Cash Flow	29,483	12,567	4,105	20,896	2,608	13,584
Free Cash Flow Per Share	54.60	23.27	7.60	38.70	4.83	25.16
Dividend Per Share	30.000	30.000	10.000	20.000	27.500	13.333
Dividend Growth	200.00%	200.00%	-50.00%	-27.27%	106.25%	-
Gross Margin	41.27%	44.18%	48.31%	52.28%	53.00%	49.13%
Operating Margin	28.50%	34.68%	36.19%	40.03%	40.29%	35.78%
Profit Margin	13.58%	17.61%	19.50%	21.22%	20.00%	18.06%
Free Cash Flow Margin	32.27%	12.64%	4.48%	24.81%	3.48%	22.53%
EBITDA	29,352	36,773	35,071	35,518	31,733	22,940
EBITDA Margin	32.13%	36.98%	38.26%	42.17%	42.41%	38.05%
D&A For EBITDA	3,315	2,280	1,893	1,802	1,588	1,368
EBIT	26,036	34,493	33,178	33,716	30,145	21,572
EBIT Margin	28.50%	34.68%	36.19%	40.03%	40.29%	35.78%
Effective Tax Rate	50.37%	48.22%	49.31%	48.93%	49.94%	48.38%
Revenue as Reported	91,367	99,449	91,668	84,232	74,828	60,291

Source: S&P Global Market Intelligence. Standard template. Financial Sources.